Cargando…
Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?
BACKGROUND: Increased investment and commitment to malaria prevention and treatment strategies across Africa has produced impressive reductions in the incidence of this disease. Nevertheless, it is clear that further interventions will be necessary to meet the international target of a reversal in t...
Autores principales: | Ogutu, Bernhards, Tiono, Alfred B, Makanga, Michael, Premji, Zulfiqarali, Gbadoé, Adama Dodji, Ubben, David, Marrast, Anne Claire, Gaye, Oumar |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824802/ https://www.ncbi.nlm.nih.gov/pubmed/20096111 http://dx.doi.org/10.1186/1475-2875-9-30 |
Ejemplares similares
-
Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
por: Kern, Steven E, et al.
Publicado: (2011) -
Treatment of Asymptomatic Carriers of Plasmodium falciparum with Artemether–Lumefantrine: Impact on the Prevalence of Anemia
por: Tiono, Alfred B., et al.
Publicado: (2013) -
Efficacy and Safety of Artemether-Lumefantrine in the Treatment of Acute, Uncomplicated Plasmodium falciparum Malaria: A Pooled Analysis
por: Makanga, Michael, et al.
Publicado: (2011) -
The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence
por: Premji, Zulfiqarali G, et al.
Publicado: (2008) -
The clinical efficacy of artemether/lumefantrine (Coartem(®))
por: Makanga, Michael, et al.
Publicado: (2009)